Singapore Neurology Devices Market Size, Share, and COVID-19 Impact Analysis, By Product (Neurostimulation Devices, Neurosurgery Devices, Interventional Neurology Devices, Cerebrospinal Fluid Devices, and Others), By End User (Hospitals, Neurology Clinics, and Ambulatory Care Centers), and Singapore Neurology Devices Market Insights, Industry Trend, Forecasts to 2033

Industry: Healthcare

RELEASE DATE Nov 2024
REPORT ID SI7196
PAGES 189
REPORT FORMAT PathSoft

Singapore Neurology Devices Market Insights Forecasts to 2033

  • The Market Size is Growing at a CAGR of 7.6% from 2023 to 2033
  • The Singapore Neurology Devices Market Size is Expected to hold a significant share by 2033

 

Singapore Neurology Devices Market

Get more details on this report -

Request Free Sample PDF

The Singapore Neurology Devices Market Size is anticipated to hold a significant share by 2033, Growing at a CAGR of 7.6% from 2023 to 2033. The increasing prevalence of neurological conditions, demand for minimally invasive procedures, expansion of the healthcare system, and technological development are driving the growth of the neurology devices market in the Singapore.     

 

Market Overview

Neurology devices refer to the medical equipment or devices that are used for the diagnosis, treatment, monitoring, and/or prevention of neurological disorders or injuries. Physiological processes associated with the nervous system are supported by these devices, thereby enhancing patient outcomes and improving quality of life. The need for neurological devices is heightened by the increasing prevalence of neurological disorders including epilepsy and stroke as well as increased demand for early diagnosis. Research on medical devices is ongoing among a medical practitioner and researcher, which raises the need for advanced equipment that provides precise diagnosis and improve patient outcomes. As a result, the market is growing as a result of increased R&D in the medical device sector, increased funding for the construction of healthcare facilities, and government initiatives to support the expansion of the medical device industry. The emergence of digital therapeutics in neurology and minimally invasive neurosurgical devices are offering lucrative market growth opportunities.

 

Report Coverage

This research report categorizes the market for the Singapore neurology devices market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Singapore neurology devices market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the Singapore neurology devices market.

 

Singapore Neurology Devices Market Report Coverage

Report CoverageDetails
Base Year:2023
Forecast Period:2023-2033
Forecast Period CAGR 2023-2033 :7.6%
Historical Data for:2019-2022
No. of Pages:189
Tables, Charts & Figures:110
Segments covered:By Product, By End User
Companies covered::Medtronic, Optima Medical, Abbott Laboratories, Natus Medical, Nihon Kohden, and Others.
Pitfalls & Challenges:Covid-19 Empact, Challenges, Growth, Analysis.

Get more details on this report -

Request Free Sample PDF
 

Driving Factors

The increasing prevalence of neurological disorders including dementia and Parkinson’s disease is anticipated to propel the market demand. The use of specialized instruments in minimally invasive neurosurgery by doctors to minimize the disruption of brain tissue, nerves, and blood vessels is driving the market. With a total health expenditure of 4·47% of GDP in 2016, Singapore is attaining favorable health results. The expanding healthcare system is contributing to driving the neurology devices market. The use of technological advancements including neurotechnology is driving the neurology devices market.     

 

Restraining Factors

The challenges associated with compliance with the stringent regulatory requirements for medical devices are challenging the Singapore neurology devices market.

 

Market Segmentation

The Singapore Neurology Devices Market share is classified into product and end user.

  • The neurostimulation devices segment dominated the Singapore neurology devices market during the forecast period.       

Based on the product, the Singapore neurology devices market is divided into neurostimulation devices, neurosurgery devices, interventional neurology devices, cerebrospinal fluid devices, and others. Among these, the neurostimulation devices segment dominated the Singapore neurology devices market during the forecast period. Neurostimulation refers to the use of an implanted medical device to modify and change brain activity for therapeutic purposes. The upsurging advancement in neurostimulation technologies is driving the market growth in the neurostimulation devices segment.  

 

  • The hospitals segment is anticipated to hold the largest market share during the forecast period.

The Singapore neurology devices market is segmented by end user into hospitals, neurology clinics, and ambulatory care centers. Among these, the hospitals segment is anticipated to hold the largest market share during the forecast period. Hospital neurological procedures are on the rise, and healthcare infrastructure is becoming more developed. The hospitals have a neurology department with EEG devices, neuroimaging systems, and neurosurgical tools. The presence of leading medical facilities in the country is driving the market.

 

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the Singapore neurology devices market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

 

List of Key Companies

  • Medtronic
  • Optima Medical
  • Abbott Laboratories
  • Natus Medical
  • Nihon Kohden
  • Others

 

Key Target Audience

  • Market Players
  • Investors
  • End-users
  • Government Authorities 
  • Consulting And Research Firm
  • Venture capitalists
  • Value-Added Resellers (VARs)

 

Market Segment

This study forecasts revenue at Singapore, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Singapore Neurology Devices Market based on the below-mentioned segments:

 

Singapore Neurology Devices Market, By Product

  • Neurostimulation Devices
  • Neurosurgery Devices
  • Interventional Neurology Devices
  • Cerebrospinal Fluid Devices
  • Others

 

Singapore Neurology Devices Market, By End User

  • Hospitals
  • Neurology Clinics
  • Ambulatory Care Centers

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies